Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $103.70 | Total: $518.50 |
| 1 | 10 | $87.84 | Total: $878.40 |
| 1 | 25 | $74.42 | Total: $1,860.50 |
| 1 | 50 | $63.44 | Total: $3,172.00 |
| 1 | 100 | $54.90 | Total: $5,490.00 |
Overview
Pomisartan (BIBR-363) is a small molecule angiotensin type 1 receptor (AT1R) antagonist that is used in the treatment of cardiovascular disease, studying heart failure and hypertensio
Chemical Properties
| Molecular Formula | C31H30N4O2 |
| Molecular Weight | 490.6 |
| CAS Numbers | 144702-17-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(N1C=2C(N=C1CC)=C(C)C=C(C2)C3=CN4C(=N3)CCCC4)C5=CC=C(C=C5)C6=C(C(O)=O)C=CC=C6 |
Storage and Handling
0C Short Term, -20C Long Term
References
Hecht A, et al. PKPD study of BIBR 363 CL2, a long?lasting angiotensin II [A?II] antagonist. Prediction of optimal doses for multiple dosing from single dose results. Clinical Pharmacology & Therapeutics. 1996;59[2] 163-163.